SPOTLIGHT -
Most primary care physicians support school-administered vaccination programs to bolster vaccination rates among the pediatric population.
Antiviral therapeutics for pediatric influenza, COVID-19, herpes
Ashley Gyura, DNP, CPNP-PC, provides updates presented at the 2024 NAPNAP National Conference, highlighting antiviral therapeutics for influenza, COVID-19, and herpes, among others.
Food Insecurity and the Dangers of Infant Formula Dilution
This is serious: The results of a measles outbreak have harmful outcomes
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics.
Demystifying Infant Formula
Pemivibart receives EUA to prevent pre-exposure prophylaxis of COVID in immunocompromised adolescents
The initial dose of pemivibart is 4500 mg, which is administered as a single intravenous infusion. A repeat 4500 mg dose should be administered every 3 months if ongoing protection is needed, stated the FDA.
CDC: More measles cases reported in 2024 than all of 2023
As of March 21, 2024, 64 measles cases have been reported to the CDC by 17 jurisdictions.